Recent Updates
Recently added Catalysts
IMMP

Immutep Announces Improving Data from the Phase II TACTI-002 Study

Saturday, May 30, 2020 1 min read
Key Takeaway: Immutep Announces Improving Data from the Phase II TACTI-002 Study

Full Press Release Details

Immutep Announces Improving Data from the Phase II TACTI-002 Study.
Tags: IMMP Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: May 30, 2020